Details of the Drug Formulaction

General Information of Drug Formulation (ID: F02523)

• Formulation Name: Bicalutamide 50 mg tablet
• Company: AstraZeneca

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Bicalutamide	(DMZMSPF)	Prostate cancer	2C82.0	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Polyethylene glycol 300	(E00651)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent